Biopharma

Toward a More Proactive Health Care System

Dr. Alexandra Bause explains how today’s reactive approach provides sick care, not health care—and how biopharma strives to change that.

The Future of Integrated Evidence Planning in Biopharma

Biopharma companies can promote the success of product launches by initiating cross-functional collaboration on evidence generation early in the development process.

The Second Opinion That Unlocks Best-in-Class Pharma Launches

The Team B approach involves assembling an independent cross-functional team to conduct rapid reviews of launch plans and market conditions for new pharmaceutical products.

Complaint Management Is a Powerful Source of Value in Health Care

Biopharma and medtech companies that adopt a digital-native approach can generate better outcomes, lower costs, and greater customer satisfaction.

New Drug Modalities Offer Promise and Peril

Gene therapy, stem cells, and other advances are changing the way complex diseases are treated. To capitalize, biopharma and biotech companies need to make strategic decisions about where to focus their efforts.

Bold Advances in Health Care

Confronting the Colorectal Cancer Challenge

Chief Commercial Officer Everett Cunningham describes Exact Sciences’ efforts to boost awareness of this deadly disease.

Health Care Payers, Providers, Systems, and Services

Investing in the People of the Public Health System

Lessons learned during COVID-19 present an opportunity to improve the US public health system. Expanding practitioners’ capacities in decision-making, communication, and working with data is a critical step.

The Existential Threat to US Hospitals

The finances of the US health system are weak. If systemic issues are not resolved, the situation will worsen, with detrimental consequences for patient care and care equity.

How Health Insurers Can Keep Talent and Cut Costs

A confluence of factors means the time-tested approaches to cost control won’t work. Insurers need to rethink how they achieve more with less while maintaining a strong customer focus and employee value proposition.

Price Transparency in US Health Care Demands Swift Action

A new regulation makes detailed pricing data widely available for the first time. Providers and insurers need to prepare now for a changed competitive playing field.

Medical Devices and Technology

Medtech’s Generative AI Opportunity

The technology has a range of uses in medtech, and the main challenge is knowing how and where to start. Here are 60 ways to generate quick wins.

MedTech’s Green Moment Is Here

Medical technology companies play a big part in health care’s carbon emissions problem, both at the patient and provider levels. Fortunately, these firms can reduce their footprint affordably.

An Rx for Launching Software as a Medical Device

Here’s what to keep in mind when developing and commercializing software as a medical device.

For Cutting-Edge Innovations, the US Pulls Ahead of the EU in Medtech Regulation

A sea change is underway in how companies win regulatory approval for new health care products—particularly in the use of digital technology—and which markets they prioritize.

Global Health

How Public-Health Leaders Can Fight the Next Pandemic

COVID-19 offered valuable lessons in combating epidemic-level disease. Four measures can help institutionalize what we’ve learned.

BCG Executive Perspectives

BCG Executive Perspectives offer insights on global topics that matter most to leaders in the public and private sectors. Explore these topics and read the latest thinking from BCG's experts below.

Reimagining Global Health After the Coronavirus

What has worked, what can be improved, and what needs to be reimagined so that we are better prepared for the next pandemic and better able to improve health in the world’s poorest nations?

The Future of Digital Health

Experts across BCG and BCG X talk about the trends and opportunities that lie ahead for the digital health care market.

• Anticipating the Spread of COVID-19 with Scenario Planning

  BCG’s scenario-planning tool, PLAN, helps you explore the potential impact of COVID-19 in the United States at a region, state, and county level.
• BD’s Vincent Forlenza on Transforming in a Rapidly Changing Industry

  Vincent Forlenza, CEO of BD, has navigated multibillion-dollar acquisitions while driving a full-scale organizational transformation. BD’s success, amid enormous change, hinges on its purpose-driven culture.
• Karalee Close on The Digital Opportunity in Healthcare

  Using digital to harness the next generation of science and the exponential growth of health care data.
• Accelerating Drug Development Today

  Sit in on a conversation with BCG pharma leaders as they discuss advancing drug development with new tools, real-world data, digitization, and collaboration across cross-functional teams.
• Using Big Data to Measure Health Care Outcomes

  According to BCG's Sanjay Saxena, the opportunity for using big data and analytics in measuring outcomes is huge. But the trick for payers and providers will be understanding the data—and knowing which questions to ask about it.
• Jon Kaplan on Health Care Payers

  BCG’s Jon Kaplan explains how health care payers can provide the strongest portfolio of product offerings and best service in today’s marketplace.